CP Reports Store
Welcome to the home of CP Reports, we are the only publisher of life science deal term reports in the industry.
CP Reports Store offers over 100 report titles that focus upon different deal types and technology or therapy areas including licensing, collaborative R&D, co-promotion, biomarkers, diagnostics, oncology, immunology all of which provide a detailed insight into the latest life science deal making trends.
Browse our reports by type to find your ideal match.
- Deal type reports
- Industry sector reports
- Stage partnered reports
- Technology reports
- Therapy reports
- Subscription services
Our reports are updated regularly and include full coverage of the latest deals in the chosen report type.
Unsure which report to select? Contact our report analysts who will assist your decision.
-
Diagnostic Imaging Collaboration and Licensing Deals 2016-2024November 2024$3,995.00Diagnostic Imaging Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2016 to 2024
Learn More -
Molecular Diagnostics Collaboration and Licensing Deals 2016-2024November 2024$3,995.00Molecular Diagnostics Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2016 to 2024
Learn More -
Stem Cell Collaboration and Licensing Deals 2010-2024November 2024$3,995.00Stem Cell Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2010 to 2024
Learn More -
Medical Device Collaboration and Licensing Deals 2016-2024November 2024$3,995.00Medical Device Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2016 to 2024
Learn More -
Microbiome Collaboration and Licensing Deals 2016-2024November 2024$3,995.00Microbiome Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2016 to 2024
Learn More -
Genomic Collaboration and Licensing Deals 2018-2024November 2024$3,995.00Genomics Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2018 to 2024
Learn More -
Gene Editing Collaboration and Licensing Deals 2016-2024November 2024$3,995.00Gene Editing Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2016 to 2024
Learn More -
Viral Vector Collaboration and Licensing Deals 2016-2024November 2024$3,995.00Viral Vector Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2016 to 2024
Learn More -
Cell Therapy Collaboration and Licensing Deals 2016-2024November 2024$3,995.00Cell Therapy Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2016 to 2024
Learn More -
Precision Medicine in Oncology Collaboration and Licensing Deals 2016-2024November 2024$3,995.00Precision Medicine in Oncology Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2016 to 2024
Learn More
